A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old

Clinical trial NCT04997239 · COMPLETED

Trial details

NCT number: NCT04997239
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2021-10-10
Primary completion: 2021-10-30
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.